Medtech reconsiders restructure

16

MEDTECH Holdings (MedTech) is considering a number of transactions that would see it transform to an investment holding company.
Earlier this year, the diversified conglomerate announced that it had terminated negotiations to sell some of its assets and the acquisition of a business in a different sector, which it had made public in 2019.

“Shareholders are advised that discussions which involve a potential series of transactions at holding company level to transform MedTech into an investment holding company with the economic rights to separate investments or portfolios of investments belonging to the owners of different classes of shares are ongoing,” the company said last week in a statement, adding that it is also involved in discussions “to purchase a minority stake in a private company, the economic rights to which would belong to a separate class of shares and which would constitute a category one transaction” in terms of the Zimbabwe Stock Exchange (ZSE) listing rules.